Browsing by Author "Millán, Mónica"

Now showing items 1-8 of 8

    • A multitrait genetic study of hemostatic factors and hemorrhagic transformation after stroke treatment 

      Gallego-Fábrega, Cristina; Temprano-Sagrera, Gerard; Cárcel-Márquez, Jara; Muiño, Elena; Cullel, Natalia; Lledós, Miquel; Llucià-Carol, Laia; Martín-Campos, Jesús M.; Sobrino, Tomás; Castillo, José; Millán, Mónica; Muñoz-Narbona, Lucía; López-Cancio Martínez, Elena; Ribó, Marc; Álvarez-Sabín, José; Jiménez-Conde, Jordi; Roquer, Jaume; Tur, Silvia; Obach, Victor; Arenillas, Juan; Segura, Tomás; Serrano-Heras, Gemma; Martí-Fàbregas, Joan; Freijo Guerrero, María del Mar; Moniche Álvarez, Francisco; Castellanos, María del Mar; Morrison, Alana C.; Smith, Nicholas L.; de Vries, Paul S.; Fernández-Cadenas, Israel; Sabater-Lleal, María (Elsevier, 2023-12-15)
      [Abstract] Background: Thrombolytic recombinant tissue plasminogen activator (r-tPA) treatment is the only pharmacologic intervention available in the ischemic stroke acute phase. This treatment is associated with an ...

    • Association of high serum levels of growth factors with good outcome in ischemic stroke: a multicenter study 

      Sobrino, Tomás; Rodríguez-Yáñez, Manuel; Campos, Francisco; Iglesias-Rey, Ramón; Millán, Mónica; Pérez de la Osa, Natalia; Dávalos, Antonio; Delgado-Mederos, Raquel; Martínez-Domeño, Alejandro; Martí-Fábregas, Joan; Castellanos, María del Mar; Serena, Joaquín; Lago, Aida; Díez-Tejedor, Exuperio; Castillo, José (Springer Nature, 2019-11-25)
      [Abstract] The main objective of this research work was to study the association of serum levels of growth factors (GF) and SDF-1α with the functional outcome and reduction of lesion volume in ischemic stroke patients. In ...

    • Blood biomarker panels for the early prediction of stroke‐associated complications 

      Faura, Júlia; Bustamante, Alejandro; Reverté, Silvia; García-Berrocoso, Teresa; Millán, Mónica; Castellanos, María del Mar; Lara-Rodríguez, Blanca; Zaragoza, Josep; Ventura, Oriol; Hernández-Pérez, María; van Eeendenburg, Cecile; Cardona, Pere; López-Cancio, Elena; Cánovas, David; Serena, Joaquín; Rubiera, Marta; Dávalos, Antoni; Montaner, Joan (American Heart Association, 2021-02-26)
      [Abstract] Background. Acute decompensated heart failure (ADHF) and respiratory tract infections (RTIs) are potentially life‐threatening complications in patients experiencing stroke during hospitalization. We aimed to ...

    • Blood biomarkers predictive of epilepsy after an acute stroke event 

      Abraira, Laura; Santamarina, Estevo; Cazorla, Sonia; Bustamante, Alejandro; Quintana, Manuel; Toledo, Manuel; Fonseca, Elena; Grau-López, Laia; Jiménez, Marta; Ciurans, Jordi; Becerra, Juan Luis; Millán, Mónica; Hernández-Pérez, María; Cardona, Pere; Terceño, Mikel; Zaragoza, Josep; Cánovas, David; Gasull, Teresa; Ustrell, Xavier; Rubiera, Marta; Castellanos, María del Mar; Montaner, Joan; Álvarez-Sabín, Jose (John Wiley & Sons, 2020-08-28)
      [Abstract] Objective: Blood biomarkers have not been widely investigated in poststroke epilepsy. In this study, we aimed to describe clinical factors and biomarkers present during acute stroke and analyze their association ...

    • Mechanical thrombectomy with the Solitaire AB device in large artery occlusions of the anterior circulation: a pilot study 

      Castaño, Carlos; Dorado, Laura; Guerrero, Cristina; Millán, Mónica; Gomis, Meritxell; Pérez de la Ossa, Natalia; Castellanos, María del Mar; García, María Rosa; Domenech, Sira; Dávalos, Antoni (American Heart Association, 2010-06-10)
      [Abstract] Background and purpose: To describe the safety and effectiveness of a self-expanding and fully retrievable stent (Solitaire AB; ev3 Inc, Plymouth, MN) in revascularization of patients with acute ischemic ...

    • RP11-362K2.2:RP11-767I20.1 genetic variation is associated with post-reperfusion therapy parenchymal hematoma: a GWAS meta-analysis 

      Muiño, Elena; Cárcel-Márquez, Jara; Carrera, Caty; Llucià-Carol, Laia; Gallego-Fábrega, Cristina; Cullel, Natalia; Lledós, Miquel; Castillo, José; Sobrino, Tomás; Campos, Francisco; Rodríguez-Castro, Emilio; Millán, Mónica; Muñoz-Narbona, Lucía; Bustamante, Alejandro; López-Cancio Martínez, Elena; Ribó, Marc; Álvarez-Sabín, José; Jiménez-Conde, Jordi; Roquer, Jaume; Giralt-Steinhauer, Eva; Soriano-Tárraga, Carolina; Vives-Bauza, Cristófol; Díaz Navarro, Rosa; Tur, Silvia; Obach, Victor; Arenillas, Juan; Segura, Tomás; Serrano-Heras, Gemma; Martí-Fàbregas, Joan; Delgado-Mederos, Raquel; Camps-Renom, Pol; Prats-Sánchez, Luis; Guisado, Daniel; Guasch, Marina; Marin, Rebeca; Martínez-Domeño, Alejandro; Freijo Guerrero, María del Mar; Moniche Álvarez, Francisco; Cabezas, Juan Antonio; Castellanos, María del Mar; Krupinsky, Jerzy; Strbian, Daniel; Tatlisumak, Turgut; Thijs, Vincent; Lemmens, Robin; Slowik, Agnieszka; Pera, Joanna; Heitsch, Laura; Ibáñez, Laura; Cruchaga, Carlos; Dhar, Rajat; Lee, Jin-Moo; Montaner, Joan; Fernández-Cadenas, Israel (MDPI, 2021-07-16)
      [Abstract] Stroke is one of the most common causes of death and disability. Reperfusion therapies are the only treatment available during the acute phase of stroke. Due to recent clinical trials, these therapies may increase ...

    • Serum cellular fibronectin and matrix metalloproteinase-9 as screening biomarkers for the prediction of parenchymal hematoma after thrombolytic therapy in acute ischemic stroke: a multicenter confirmatory study 

      Castellanos, María del Mar; Sobrino, Tomás; Millán, Mónica; García, María M.; Arenillas, Juan; Nombela, Florentino; Brea, David; Pérez de la Ossa, Natalia; Serena, Joaquín; Vivancos, José; Castillo, José; Dávalos, Antoni (American Heart Association, 2007-05-03)
      [Abstract] Background and purpose: Plasma levels of cellular fibronectin (c-Fn) > or =3.6 microg/mL and of matrix metalloproteinase-9 (MMP-9) > or =140 ng/mL have been associated with parenchymal hematoma (PH) after ...

    • Single nucleotide variations in ZBTB46 are associated with post-thrombolytic parenchymal haematoma 

      Carrera, Caty; Cárcel-Márquez, Jara; Cullel, Natalia; Torres-Águila, Nuria; Muiño, Elena; Castillo, José; Sobrino, Tomás; Campos, Francisco; Rodríguez-Castro, Emilio; Llucià-Carol, Laia; Millán, Mónica; Muñoz-Narbona, Lucía; López-Cancio, Elena; Bustamante, Alejandro; Ribó, Marc; Álvarez-Sabín, José; Jiménez-Conde, Jordi; Roquer, Jaume; Giralt-Steinhauer, Eva; Soriano-Tárraga, Carolina; Mola-Caminal, Marina; Vives-Bauza, Cristófol; Díaz Navarro, Rosa; Tur, Silvia; Obach, Victor; Arenillas, Juan; Segura, Tomás; Serrano-Heras, Gemma; Martí-Fábregas, Joan; Delgado-Mederos, Raquel; Freijo Guerrero, María del Mar; Moniche, Francisco; Cabezas, Juan Antonio; Castellanos, María del Mar; Gallego-Fábrega, Cristina; González-Sánchez, Jonathan; Krupinsky, Jurek; Strbian, Daniel; Tatlisumak, Turgut; Thijs, Vincent; Lemmens, Robin; Slowik, Agnieszka; Pera, Johanna; Kittner, Steven; Cole, John; Heitsch, Laura; Ibáñez, Laura; Cruchaga, Carlos; Lee, Jin-Moo; Montaner, Joan; Fernández-Cárdenas, Israel (Oxford University Press, 2021-03-16)
      [Abstract] Haemorrhagic transformation is a complication of recombinant tissue-plasminogen activator treatment. The most severe form, parenchymal haematoma, can result in neurological deterioration, disability, and death. ...